Bills · Sep 2011 Special Session
providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
- Introduced, stopped here
- Passes Senate, not reached
- Passes Assembly, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill provides immunity from liability to a manufacturer or a seller of a drug
or device for any claim based on strict liability for a defect in the drug or device if the
drug or device was approved by the federal Food and Drug Administration (FDA) at
the time the drug or device left the control of the manufacturer or seller. The bill also
provides immunity from liability to a manufacturer or seller of a drug or device for
any claim based on the failure to warn of the risk of the drug or device if labeling for
the drug or device was made available to the consumer or the person who prescribed
the drug or device and the labeling was in compliance with applicable standards
established by the FDA at the time the drug or device left the control of the
manufacturer or seller.
The bill defines a "device" as an instrument, apparatus, implement, machine,
contrivance, implant, in vitro reagent or other similar or related article, including
any component, part, or accessory, which does not achieve any of its principal
intended purposes through chemical action within or on the body of a person or other
animal, is not dependent upon being metabolized for the achievement of any of its
principal intended purposes, and is: (a) recognized by the U.S. pharmacopoeia and
national formulary or official homeopathic pharmacopoeia of the United States, or
any supplement to either of them; (b) intended for use in the diagnosis, cure,
mitigation, treatment, or prevention of disease or other conditions in persons or other
animals; or (c) intended to affect the structure or any function of the body of persons
or other animals. The bill defines a "drug" as: 1) any substance recognized as a drug
in the official U.S. pharmacopoeia and national formulary or official homeopathic
pharmacopoeia of the United States or any supplement to either of them; 2) any
substance intended for use in the diagnosis, cure, mitigation, treatment, or
prevention of disease or other conditions in persons or other animals; 3) any
substance other than a device or food intended to affect the structure or any function
of the body of persons or other animals; or 4) any substance intended for use as a
component of any article specified in items 1) to 3), above, but does not include gases
or devices or articles intended for use or consumption in or for mechanical, industrial,
manufacturing, or scientific applications or purposes. The bill defines a
"manufacturer" as an entity licensed or approved by the FDA to engage in the
manufacture of drugs or devices. The bill defines an "entity" as a corporation,
partnership, or association.
Sponsors
Full history
- Oct 11, 2011 · Senate
Introduced by committee on Senate Organization, by request of Governor Scott Walker, Senator Zipperer, and Representative Kooyenga
- Oct 11, 2011 · Senate
Read first time and referred to committee on Judiciary, Utilities, Commerce, and Government Operations
- Oct 11, 2011 · Senate
Senator Zipperer added as a coauthor
- Oct 11, 2011 · Senate
Representative Kooyenga added as a cosponsor
- Dec 13, 2011 · Senate
Failed to pass pursuant to Senate Joint Resolution 1